Biopharma manufacturers need adaptable, efficient facilities that support varied products and production demands. Process intensification (PI) and perfusion processes can help meet these challenges.
Sartorius’ modular intensified seed train solution — the Biostat® RM, Biostat® STR, and Biobrain® — increase flexibility, productivity and efficiency in biopharma manufacturing. Watch the webinar to learn how.
What Will You Learn:
Discover a fully integrated seed train solution — Biostat® RM, Biostat® STR, and Biobrain® automation.
Explore the flexible modular concept of the perfusion-enabled intensified seed train.
Assess the time/cost benefits based on selected seed train configurations.
Meet Our Experts:
Dr. Yuliya Mikhed
Product Manager Biostat RM Bioreactors
Dr. Yuliya Mikhed, product manager at Sartorius, holds global responsibility for the Biostat® RM portfolio, including hardware and corresponding single-use consumables.
Yuliya studied medicinal chemistry at the University of Illinois at Chicago and earned a Doctor of Philosophy degree in molecular biology from Johannes Gutenberg University in Mainz, Germany. She published multiple peer-reviewed articles in the field of free radical biology and DNA mutagenesis.
Ahmed Youssef
Senior Manager, Upstream Process Development, Ascend Advanced Therapies
Ahmed Youssef is a senior manager of upstream process development at Ascend. He leads the team responsible for developing safe and effective gene therapies for partners using AAVs. In this role, he draws on more than 12 years of bioprocessing expertise to take AAV gene therapies from the lab to patients by ensuring they can be produced on a large scale with the best possible quality.
Ahmed has a comprehensive background in process development, scale-up, process transfer, and team leadership. He has worked across molecules (mAbs, AAVs, and hormones), including those already in late-stage clinical trials.